Skip to main content
Clinical Trials/ITMCTR2000003113
ITMCTR2000003113
Recruiting
Phase 1

Clinical observation and evaluation of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in Hubei 672 Orthopaedics Hospital of Integrated Chinese&Western Medicine

Hubei 672 Orthopaedics Hospital of Integrated Chinese&Western Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Hubei 672 Orthopaedics Hospital of Integrated Chinese&Western Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Hubei 672 Orthopaedics Hospital of Integrated Chinese&Western Medicine

Eligibility Criteria

Inclusion Criteria

  • (1\) mild / general patients who meet the diagnostic criteria of the Protocol;
  • (2\) Aged \>\=18 years;
  • (3\) Obtain patients' informed consent.

Exclusion Criteria

  • (1\) Patients who cannot guarantee medication compliance during treatment, and patients who have difficulty in oral administration;
  • (2\) Patients more than 7 days after diagnosis;
  • (3\) Patients with severe primary respiratory diseases, or patients with other pathogenic microbial pneumonia that needs to be identified with NCP;
  • (4\) pregnant women, those with positive urine pregnancy tests;
  • (5\) Combined with other systemic malignant diseases such as malignant tumors and mental diseases;
  • (6\) Patients with other serious diseases such as uremia and severe heart failure;
  • (7\) Those who are allergic to the test drugs or who are intolerant to taking the drugs;
  • (8\) Patients that the investigator considers unsuitable to participate in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials